BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15650004)

  • 21. Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates.
    Fenollar F; Trani M; Davoust B; Salle B; Birg ML; Rolain JM; Raoult D
    J Infect Dis; 2008 Mar; 197(6):880-7. PubMed ID: 18419351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of non-enterococcal intrinsic glycopeptide-resistant Gram-positive organisms.
    Vay C; Cittadini R; Barberis C; Hernán Rodríguez C; Perez Martínez H; Genero F; Famiglietti A
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):183-8. PubMed ID: 17049799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.
    Anderson R; Steel HC; Cockeran R; Smith AM; von Gottberg A; de Gouveia L; Brink A; Klugman KP; Mitchell TJ; Feldman C
    J Antimicrob Chemother; 2007 Feb; 59(2):224-9. PubMed ID: 17218449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BSAC standardized disc susceptibility testing method (version 7).
    Andrews JM;
    J Antimicrob Chemother; 2008 Aug; 62(2):256-78. PubMed ID: 18474513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microorganisms isolated from middle ear cultures and their antibacterial susceptibility in patients with chronic suppurative otitis media].
    Gül HC; Kurnaz A; Turhan V; Oncül O; Pahsa A
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(4):164-8. PubMed ID: 16905907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.
    Critchley IA; Green LS; Young CL; Bullard JM; Evans RJ; Price M; Jarvis TC; Guiles JW; Janjic N; Ochsner UA
    J Antimicrob Chemother; 2009 May; 63(5):954-63. PubMed ID: 19258353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of Listeria monocytogenes from food products.
    Aarestrup FM; Knöchel S; Hasman H
    Foodborne Pathog Dis; 2007; 4(2):216-21. PubMed ID: 17600489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA.
    Angelakis E; Biswas S; Taylor C; Raoult D; Rolain JM
    J Antimicrob Chemother; 2008 Jun; 61(6):1252-5. PubMed ID: 18334491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia.
    Morrissey I; Ge Y; Janes R
    Int J Antimicrob Agents; 2009 Jun; 33(6):515-9. PubMed ID: 19203863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy for Whipple's disease.
    Knaapen HK; Barrera P
    J Antimicrob Chemother; 2007 Sep; 60(3):457-8. PubMed ID: 17623695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of antibiotic susceptibility within lactic acid bacteria strains isolated from wine.
    Rojo-Bezares B; Sáenz Y; Poeta P; Zarazaga M; Ruiz-Larrea F; Torres C
    Int J Food Microbiol; 2006 Oct; 111(3):234-40. PubMed ID: 16876896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients.
    Wilson AP; Cepeda JA; Hayman S; Whitehouse T; Singer M; Bellingan G
    J Antimicrob Chemother; 2006 Aug; 58(2):470-3. PubMed ID: 16735420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products.
    Masco L; Van Hoorde K; De Brandt E; Swings J; Huys G
    J Antimicrob Chemother; 2006 Jul; 58(1):85-94. PubMed ID: 16698847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chorioretinitis and vitreitis due to Tropheryma whipplei after transplantation: case report and review.
    Razonable RR; Pulido JS; Deziel PJ; Dev S; Salomão DR; Walker RC
    Transpl Infect Dis; 2008 Dec; 10(6):413-8. PubMed ID: 18564981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei.
    Bentley SD; Maiwald M; Murphy LD; Pallen MJ; Yeats CA; Dover LG; Norbertczak HT; Besra GS; Quail MA; Harris DE; von Herbay A; Goble A; Rutter S; Squares R; Squares S; Barrell BG; Parkhill J; Relman DA
    Lancet; 2003 Feb; 361(9358):637-44. PubMed ID: 12606174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use.
    Klare I; Konstabel C; Werner G; Huys G; Vankerckhoven V; Kahlmeter G; Hildebrandt B; Müller-Bertling S; Witte W; Goossens H
    J Antimicrob Chemother; 2007 May; 59(5):900-12. PubMed ID: 17369278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.